Prokidney (PROK) Change in Account Payables (2021)
Prokidney's (PROK) quarterly Change in Account Payables came in at $5000.0 in Q4 2021.
Powered by 
Analysis
Prokidney (PROK) Change in Account Payables (2021) Analysis & Trends
Prokidney (PROK) has reported Change in Account Payables for 1 consecutive years, with $5000.0 the latest figure, recorded in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 3.06 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -11.82 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 2.90 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 625,000.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.21 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 2.84 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -19.39 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1.57 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | - |